Anthonet Koen to Cross Reactions
This is a "connection" page, showing publications Anthonet Koen has written about Cross Reactions.
Connection Strength
0,046
-
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial. Lancet HIV. 2021 09; 8(9):e568-e580.
Score: 0,046